U.S. Markets closed

Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher

Zacks Equity Research

Dendreon Corp. (DNDN) was a big mover last session, as the company saw its shares rise by nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.25 to $2.81 in the past one-month time frame.

This biotechnology company has seen a mixed track record when it comes to estimate revisions. Over the past one month, 5 estimates moved north and the same number of estimates were revised lower. The Zacks Consensus Estimate however remained unchanged during this time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Dendreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the med-biomed industry may consider stocks like Actelion Ltd. (ALIOF), Amgen Inc. (AMGN) and Gilead Sciences Inc. (GILD). While Actelion holds a Zacks Rank #1 (Strong Buy), Amgen and Gilead Sciences carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

DENDREON CP (DNDN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

AMGEN INC (AMGN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

Zacks Investment Research